GLOBAL X GENOMICS & BIOTECHNOLOGY UCITS ETF - ACC

Benchmark

The Solactive Telemedicine & Digital Health Index is designed to track performance of companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.

PERFORMANCE

YTD7D30D1Y3Y5Y

Powered by

RELATED ARTICLES

New Listing

Global X signals intent in Europe with seven thematic ETF launches

Takes range of UCITS ETFs to 12

Tom Eckett

18 Nov 2021